NASDAQ : BFRI
Biofrontera Inc. — Company profile
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 0.9315 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 13.83M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Details
| Name | Biofrontera Inc. |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 94 |
| Founded | 1997 |
| Ipo Date | 2021-10-29 |
| Ceo | Hermann Luebbert |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Ipo Price | 5.00 |
| Isin | US09077D2099 |
| Cusip | 09077D209 |
| Cik | 1858685 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Hermann Luebbert Ph.D. | Chief Executive Officer, President and Chairman |
| Eugene Frederick Leffler III | Chief Financial Officer |
| George P. Jones | Chief Commercial Officer |
| Erica F. Gates CPA, M.B.A. | Vice President of Finance and Principal Accounting Officer |
| Jon Lyons M.B.A., Ph.D. | Vice President of Scientific and Medical Affairs |
| Daniel Hakansson J.D. | Senior Corporate Counsel |
| Samantha Widdicombe | Senior Vice President of Sales and Strategic Accounts |
Contact
| Address | 660 Main Street, 1st Floor, Woburn, Massachusetts 01801, United States |
| Phone | 781 245 1325 |
| Website | https://www.biofrontera-us.com |